Overview
Frank Slovick is a Hematologist Oncology specialist and a Hematologist in Kansas City, Missouri. Dr. Slovick is rated as an Experienced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). His top areas of expertise are Thrombocytopenia, Hemangioma Thrombocytopenia Syndrome, Multiple Myeloma, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Slovick is currently accepting new patients.
His clinical research consists of co-authoring 1 peer reviewed article. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- EPO
- HMO
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Select Physical Therapy Holdings Inc
Marc Hoffmann is a Hematologist Oncology specialist and a Hematologist in Independence, Missouri. Dr. Hoffmann is rated as a Distinguished provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). His top areas of expertise are Non-Hodgkin Lymphoma, B-Cell Lymphoma, Mantle Cell Lymphoma (MCL), Small Lymphocytic Lymphoma (SLL), and Bone Marrow Aspiration. Dr. Hoffmann is currently accepting new patients.
University Of Kansas Hospital Authority
Leyla Shune is a Hematologist Oncology specialist and a Hematologist in Westwood, Kansas. Dr. Shune is rated as an Elite provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). Her top areas of expertise are Relapsed Refractory Multiple Myeloma (RRMM), Multiple Myeloma, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Shune is currently accepting new patients.
University Of Kansas Hospital Authority
Vinay Raja is a Hematologist Oncology specialist and a Hematologist in Kansas City, Missouri. Dr. Raja is rated as a Distinguished provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Non-Hodgkin Lymphoma, and Lung Cancer. Dr. Raja is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- ThrombocytopeniaDr. Slovick isDistinguished. Learn about Thrombocytopenia.
- Advanced
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Slovick isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- Adult Immune ThrombocytopeniaDr. Slovick isAdvanced. Learn about Adult Immune Thrombocytopenia.
- AgranulocytosisDr. Slovick isAdvanced. Learn about Agranulocytosis.
- Aplastic AnemiaDr. Slovick isAdvanced. Learn about Aplastic Anemia.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Slovick isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Monoblastic Leukemia (AmoL)Dr. Slovick isExperienced. Learn about Acute Monoblastic Leukemia (AmoL).
- Acute Mountain SicknessDr. Slovick isExperienced. Learn about Acute Mountain Sickness.
- Acute Promyelocytic LeukemiaDr. Slovick isExperienced. Learn about Acute Promyelocytic Leukemia.
- Adult T-Cell LeukemiaDr. Slovick isExperienced. Learn about Adult T-Cell Leukemia.
- ALK-Positive Non-Small Cell Lung CancerDr. Slovick isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.